製品名
MILLIPLEX® Equine Cytokine/Chemokine Panel,
Quality Level
description
Configurable Equine Cyokine/Chemokine 23-Plex Panel
species reactivity
horse
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
sensitivity: 16.3 pg/mL
(FGF-2), sensitivity: 16.7 pg/mL
(IP-10), sensitivity: 165 pg/mL
(IFNγ), sensitivity: 25.3 pg/mL
(IL-18), sensitivity: 29.3 pg/mL
(IL-1β), sensitivity: 3.9 pg/mL
(RANTES/CCL5), sensitivity: 3.94 pg/mL
(GM-CSF), sensitivity: 340 pg/mL
(G-CSF), sensitivity: 355 pg/mL
(IL-4), sensitivity: 39-130 pg/mL
(IL-13), sensitivity: 39.1 pg/mL
(IL-1α), sensitivity: 399 ng/mL
(MCP-1), sensitivity: 457 pg/mL
(Fractalkine/CS3CL1), sensitivity: 49.2 pg/mL
(IL-12 (p70)), sensitivity: 5.2 pg/mL
(TNFα), sensitivity: 62.5 pg/mL
(IL-10), sensitivity: 7.8 pg/mL
(GRO), sensitivity: 74.3 pg/mL
(IL-8/CXCL8), sensitivity: 8.3 pg/mL
(Eotaxin/CCL11), standard curve range: 15-15,000 pg/mL
(IL-17A), standard curve range: 15-15,000 pg/mL
(IL-2), standard curve range: 15-15,000 pg/mL
(IL-5), standard curve range: 15-15,000 pg/mL
(IL-6), standard curve range: 15-15,000 pg/mL
(IP-10), standard curve range: 29-30,000 pg/mL
(IL-1β), standard curve range: 293-300,000 pg/mL
(IL-4), standard curve range: 34-35,000 pg/mL
(IL-18), standard curve range: 342-350,000 ng/mL
(MCP-1), standard curve range: 39-40,000 pg/mL
(IL-12 (p70)), standard curve range: 39-40,000 pg/mL
(IL-13), standard curve range: 4-4,000 pg/mL
(TNFα), standard curve range: 488-500,000 pg/mL
(IFNγ), standard curve range: 49-50,000 pg/mL
(IL-10), standard curve range: 5-5,000 pg/mL
(GM-CSF), standard curve range: 5-5,000 pg/mL
(RANTES/CCL5), standard curve range: 59-60,000 pg/mL
(IL-1α), standard curve range: 59-60,000 pg/mL
(IL-8/CXCL8), standard curve range: 6-6,000 pg/mL
(GRO), accuracy: 74%
(IL-17a), accuracy: 76%
(IL-6), accuracy: 78%
(FGF-2), accuracy: 82%
(G-CSF), accuracy: 83%
(IFNγ), accuracy: 83%
(IL-12 (p70)), accuracy: 85%
(IL-13), accuracy: 86%
(IL-10), accuracy: 88%
(RANTES/CCL5), accuracy: 89%
(IL-8/CXCL8), accuracy: 90%
(IL-2), accuracy: 90%
(MCP-1), accuracy: 91%
(Fractalkine/CS3CL1), accuracy: 92%
(IL-5), accuracy: 93%
(Eotaxin/CCL11), accuracy: 97%
(GRO), sensitivity: 1.4 pg/mL
(IL-6), sensitivity: 10.6 pg/mL
(IL-5), sensitivity: 13.5 pg/mL
(IL-2), sensitivity: 15.4 pg/mL
(IL-17A)
technique(s)
multiplexing: suitable
input
plasma
cell culture supernatant(s)
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: Eotaxin/CCL11, FGF-2, Fractalkine/CX3CL1, G-CSF, GM-CSF, GRO/KC, IFN-γ, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12 (p70), IL-13, IL-17A, IL-18, IP-10 (CXCL10), MCP-1, RANTES (CCL5), TNF-α
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Comprehensive 23-plex Cytokine and Chemokine Panel: Simultaneously quantify 23 critical immune mediators (including Eotaxin, FGF-2, G-CSF, IL-1α, IL-6, IL-10, TNFα, and more) in equine serum, plasma, or culture supernatant samples, providing a holistic view of the equine immune response.
- High-Throughput 96-well Format: Analyze up to 38 samples in duplicate, maximizing laboratory efficiency and sample utilization while minimizing reagent costs and hands-on time.
- In-Depth Immune Profiling: Investigate the immune response in equine models of infectious diseases, osteoarthritis, respiratory diseases, and other conditions, facilitating a better understanding of disease mechanisms and potential therapeutic targets.
- Enhanced Statistical Power: Generate multi-parameter datasets from individual samples, improving experimental design and enabling sophisticated statistical analyses for publication-quality research outcomes.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
signalword
Danger
target_organs
Respiratory Tract
保管分類
10 - Combustible liquids
wgk
WGK 3
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Eye Dam. 1 - STOT RE 2
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
関連コンテンツ
Discover the benefits of MILLIPLEX® multiplex assays, based on Luminex® xMAP® multiplex assay technology, that provide consistent, high-quality results and see how these multiplex biomarker Luminex® assays are being used to advance research.
Discover benefits of using biomarker detection multiplex immunoassays for companion and agricultural animal health research and find vet med multiplex assays.
一貫した高品質の結果をもたらすLuminex® xMAP®マルチプレックスアッセイテクノロジーに基づくMILLIPLEX® マルチプレックスアッセイの利点をご確認ください。そしてマルチプレックスバイオマーカーLuminex® アッセイが研究の発展にどのように活用されているのかをご覧ください。


